Poseida Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan '25 Jan 7, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Market Capitalization	929	321	456	426	678	-
Market Cap Growth	-	-29.47%	7.02%	-37.23%	-	-
Enterprise Value	781	169	267	288	396	-
Last Close Price	9.50	3.36	5.30	6.81	10.97	-
PS Ratio	6.08	4.97	3.49	13.63	-	-
PB Ratio	10.61	3.10	2.43	2.72	2.59	-
P/TBV Ratio	11.37	3.27	2.50	2.83	2.64	-
EV/Sales Ratio	5.18	2.61	2.05	9.22	-	-
Debt / Equity Ratio	0.95	0.82	0.47	0.39	0.24	0.43
Asset Turnover	0.51	0.21	0.42	0.10	-	-
Quick Ratio	3.14	3.10	5.41	4.76	10.30	5.73
Current Ratio	3.20	3.18	5.54	4.94	10.46	5.82
Return on Equity (ROE)	-57.63%	-84.75%	-37.23%	-59.77%	-77.27%	-242.83%
Return on Assets (ROA)	-13.11%	-25.87%	-12.06%	-27.59%	-30.51%	-51.30%
Return on Invested Capital (ROIC)	-20.57%	-34.78%	-15.18%	-32.66%	-36.84%	-80.79%
Earnings Yield	-6.54%	-38.42%	-14.05%	-29.36%	-19.14%	-
FCF Yield	-1.84%	-29.64%	-6.74%	-24.71%	-19.20%	-
Buyback Yield / Dilution	-9.93%	-25.34%	-15.61%	-72.89%	-185.27%	-3.57%
Total Shareholder Return	-9.93%	-25.34%	-15.61%	-72.89%	-185.27%	-3.57%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q